MetaCap

LifeMD (LFMD) vs Strata Critical Medical (SRTA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Strata Critical Medical (SRTA) has outperformed LifeMD (LFMD) over the past year, gaining 8.6% versus a loss of 62.5%. Over five years, SRTA leads with a -46.8% price change compared with -65.9% for LFMD. Strata Critical Medical is the larger company by market cap ($407.3 million vs $69.8 million), about 5.8 times the size.

Strata Critical Medical converts more of its revenue into profit, with a net margin of 21.0% versus 7.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

LFMD-62.47%SRTA+8.57%
+60%-4%-68%
Nov 21, 20251 yearNov 20, 2026
LFMD-68.17%SRTA-52.80%
+240%+73%-93%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

LFMD versus SRTA key metrics
MetricLFMDSRTA
Share price$1.45$4.56
Market cap$69.84M$407.30M
1-day change-9.40%-5.59%
YTD return-57.62%-5.20%
1-year return-62.47%+8.57%
5-year return-65.92%-46.79%
Forward P/E9.32—
EPS (TTM)$-0.52$-0.24
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$194.06M$197.14M
Revenue growth (YoY)+25.34%+34.28%
Net income (latest FY)$14.35M$41.35M
Gross margin85.72%20.86%
Operating margin-3.95%-11.34%
Net margin7.40%20.97%
52-week high$5.38$6.50
52-week low$1.38$3.95
Distance from 52-week high-73.14%-29.85%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+462.63%+111.18%
Average volume929.40K982.75K
Shares outstanding48.33M89.32M
Employees347327
SectorHealth CareHealth Care
IndustryMedical/Nursing ServicesMedical/Nursing Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Strata Critical Medical is about 5.8 times larger than LifeMD by market value ($407.30M vs $69.84M).
  • SRTA has outperformed LFMD by 71.0 percentage points over the past year.
  • Strata Critical Medical is more profitable, keeping 21.0 cents of every revenue dollar as net income versus 7.4 cents for LifeMD.
  • Strata Critical Medical grew revenue faster in its latest fiscal year (+34.28% vs +25.34%).

About LifeMD

LFMD stock →

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States.

Health Care · Medical/Nursing Services · 347 employees

About Strata Critical Medical

SRTA stock →

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States.

Health Care · Medical/Nursing Services · 327 employees

LFMD vs SRTA FAQ

Which is bigger, LifeMD or Strata Critical Medical?

Strata Critical Medical (SRTA) is larger, with a market capitalization of $407.30M compared with $69.84M for LifeMD (LFMD).

Which stock has performed better over the past year, LFMD or SRTA?

SRTA returned +8.57% over the past 12 months, compared with -62.47% for LFMD (price return, excluding dividends). Past performance does not predict future results.

Are LifeMD and Strata Critical Medical in the same industry?

Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.

More comparisons